[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-112-2-medical-surgical-079":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-112-2-內外科護理學-079","nurse-112-2-medical-surgical-079",112,2,79,"有關嚴重特殊傳染性肺炎 COVID-19 之護理措施，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"無休克證據，仍應給予大量輸液治療","常規性給予全身性皮質類固醇","避免使用 Nebulizer 等氣霧式治療","常規使用高流量鼻導管（High-flow Nasal Oxygen, HFNO）給氧","C",null,[],"本題考點在 COVID-19 的正確護理措施。依感染控制原則，噴霧治療(Nebulizer)等氣霧式治療會產生大量帶病毒氣溶膠，增加飛沫核擴散與醫護感染風險，故應避免使用,選 C。A 在無休克證據時應採保守輸液策略而非大量輸液，以免加重肺水腫,錯誤。B 全身性皮質類固醇僅建議用於需氧氣或呼吸支持的重症者，並非常規對所有病人給予,錯誤。D 高流量鼻導管(HFNO)同樣屬產生氣溶膠的處置，需在負壓環境與嚴格防護下審慎使用，非常規使用,錯誤。故唯 C 正確。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840782119]